5 Rocket Stocks to Buy Before Turkey Day
But with Thanksgiving's shortened trading week upon us, weary investors could very well be due for a change -- historically, Thanksgiving offers a strong push for stocks. If nothing else, market reprieves on Thursday and half of Black Friday will offer investors a chance to sit back and mentally absorb the price action that we've been dealing with of late.
Even though we're looking at a shortened week, there are still market moves worth making. That's why we're taking a closer look at five new Rocket Stocks to start the week.
For the uninitiated, "Rocket Stocks" are our list of companies with short-term gain catalysts and longer-term growth potential. To find them, I run a weekly quantitative screen that seeks out stocks with a combination of analyst upgrades and positive earnings surprises to identify rising analyst expectations, a bullish signal for stocks in any market. After all, where analysts' expectations are increasing, institutional cash often follows.
Without further ado, here's a look at this week's Rocket Stocks.
We'll start off with biopharmaceutical firm AstraZeneca plc (AZN) -- and no, it's not just because the firm's heartburn drug, Nexium, could see a sales boost come Turkey Day. AstraZeneca is a $55 billion pharmaceutical stock with an impressive portfolio of brand name drugs and a truly worldwide presence. The firm generates less than 40% of sales in the United States, and it's been working hard to increase its exposure to high-growth emerging markets.